Finance

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal

Feb 21, 2025 - 21:38
 0
AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal
Read More

Tags:

Previous Article

Walmart forecast disappoints, shares fall on consumer spending worries

Next Article

Toymaker Hasbro unveils new growth plan; 2025 revenue forecast underwhelms

Related Posts

GFL’s Investor Day Delivered. Why the Waste Hauler’s Stock Can Rise 45%.

GFL’s Investor Day Delivered. Why the Waste Hauler’s St...

Feb 28, 2025  0

Microlender Tala lands $150 million debt facility to expand Mexico business

Microlender Tala lands $150 million debt facility to ex...

Mar 19, 2025  0

I made Ina Garten's chocolate-chunk blondies. They were cheap and easy to make, and my book club couldn't get enough of them.

I made Ina Garten's chocolate-chunk blondies. They were...

Mar 16, 2025  0